Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05808257 · ClinicalTrials.gov registry record · NA
Thulium vs. Hol:YAG Laser
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
NCT05808257 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 82 participants.
The verdict
NCT05808257, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
Study Summary
This is a randomized prospective study to compare stone free rates and operative efficiency of two laser systems used during retrograde intrarenal surgery for kidney stone disease: 1. A superpulsed thulium fiber laser (thulium) 2. A pulse modulated high power holmium laser (Holmium)
Interventions
- DEVICE Thulium Fibre Laser
- DEVICE Holmium:Yttrium-Aluminum-Garnet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2022-01-07 |
| Est. Completion | 2024-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05808257
The ClinicalTrials.gov registry entry for NCT05808257 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Thulium Fibre Laser is the first listed.
NCT05808257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05808257 about?
NCT05808257 is a clinical study titled "Thulium vs. Hol:YAG Laser". This is a randomized prospective study to compare stone free rates and operative efficiency of two laser systems used during retrograde intrarenal surgery for kidney stone disease: 1. A superpulsed thulium fiber laser (thulium) 2. A pulse modulated high power holmium laser (Holmium)
What is the current status of trial NCT05808257?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2022-01-07. Estimated completion is 2024-02-01.
What interventions are being tested in trial NCT05808257?
The interventions under investigation include: Thulium Fibre Laser (DEVICE), Holmium:Yttrium-Aluminum-Garnet (DEVICE).
Who is sponsoring clinical trial NCT05808257?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.